Trade Mark Journal No.2026/018 1 May 2026

UK00004372360 13 April 2026 (5)

RIS-REZ

Class 5: Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders.

Glaxo Group Limited

Representative: Legal Brand Protection, GSK